Question-and-Answer Session
Operator
Certainly. The floor is now open for questions. (Operator Instructions). Our first question is coming from Greg Gilbert of Merrill Lynch. Please go ahead.
Greg Gilbert - Merrill Lynch
Thanks, good morning. I have a couple, first can you share what tax rate assumptions you are using for the preliminary '08 EPS goal?
Adrian Adams
Yes. Greg it's just keeping it consistent just for a comparison purposes, we've not assumed the full evaluation in that number of our NOL.
Greg Gilbert with Merrill Lynch
Okay. On LUNESTA, can you comment on the inventory levels as well as, net price during the quarter as compared to the June quarter sales? Were they a little ahead of what we were at cost, given script growth?
Mark Corrigan
Sure. We don’t comment on the net price, but we obviously can share the inventory levels. The LUNESTA inventory levels stayed relatively constant at six and half weeks. UDV XOPENEX was up a little bit; it was up from about five to five-and-half weeks, and the net change from a dollar perspective on that is about $3.5 million.
Greg Gilbert with Merrill Lynch
Was there anything temporary or of one-time nature that helped LUNESTA net sales in the quarter?
Mark Corrigan
No. I mean, that was just -- it was sort of the ongoing sales. And then the MDI, just to finish your first question was about five weeks. It stayed about the same and BROVANA was about four and a half weeks, which changed, I mean it came way down but it's a relatively small product, and so it’s not the inventory that moves around, the loss on that one still.
Greg Gilbert with Merrill Lynch
Okay. One more and I'll get back in line. Adrian, can you update us on the XOPENEX [CDB] legal situation and any contingency plans you may have in place, if there is an average generic launch next year?
Adrian Adams
It’s clear, as you know from my past, I never comment on our strategy in relation to litigation. Obviously, we are well aware of the time lines, and we feel good about our intellectual property positions. So, clearly I think the litigation is going through the normal routes. And when I am at a position to comment on any progress, I will do that. But again, I will re-emphasize that we feel good about our intellectual property position.
- To read the full transcript on Seeking Alpha, click here »
